Answers are grounded in this paper and cite their sources.
Aim: This study aimed to clarify indications under insurance coverage for measuring the serum ratio of soluble fms-like tyrosine kinase 1 to placental growth factor (sFlt-1/PlGF ratio), and to construct a flow diagram for the short-term prediction of preeclampsia (PE) using the sFlt-1/PlGF ratio in women at imminent/basal risk of preeclampsia.
No takes yet. Share an insight, caveat, or question.
Ohkuchi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: